Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Keybanc rai

BenzingaJun 5 20:40

HOOKIPA Pharma Is Maintained at Buy by HC Wainwright & Co.

HOOKIPA Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesJun 5 19:49

Express News | HC Wainwright & Co.: Maintains a buy rating on hookipa pharma (HOOK.US), adjusted from buy to buy rating, with a target price of $6.00, adjusted from $5.00.

BreakingsJun 5 19:40

HOOKIPA Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/05/2024 640.74% HC Wainwright & Co. $5 → $6 Maintains Buy 05/21/2024 517.28% RBC Capital $5 → $5 Reiter

BenzingaJun 5 19:37

H.C. Wainwright Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Raises Target Price to $6

H.C. Wainwright analyst Arthur He CFA maintains $HOOKIPA Pharma(HOOK.US)$ with a buy rating, and adjusts the target price from $5 to $6.According to TipRanks data, the analyst has a success rate of 53

Futu NewsJun 5 18:33

Express News | HOOKIPA Pharma Inc. : H.c. Wainwright Raises Target Price to $6 From $5

BreakingsJun 5 18:03